Skip to content
ChroniclesLive
  • HOME
  • WORLD
    • NEWS
  • BUSINESS
    • AUTOMOBILE
  • TECHNOLOGY
    • DIGITAL MARKETING
    • MOBILE & GADGETS
    • CRYPTO
  • TRENDING NOW
  • ART & CULTURE
    • LIFESTYLE
    • FASHION
  • HEALTH
  • EDUCATION
  • MORE
    • SPORTS
    • ENTERTAINMENT
    • POLITICS
    • TRAVEL

Novo Nordisk A/S

Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s

by Akin Smith
Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s

A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023.  George Frey | Bloomberg …

Read more

U.S. jobs report, ECB commentary

by Walter Watson
U.S. jobs report, ECB commentary

Stock price information reflected on a window at the Euronext NV stock exchange in Paris, France, on Monday, March 13, 2023.  Nathan Laine | Bloomberg | Getty Images LONDON — …

Read more

ECB interest rate decision watched closely

by Walter Watson
ECB interest rate decision watched closely

A sculpture of the Euro currency stands in the city centre of Frankfurt am Main, western Germany, on January 25, 2024. Kirill Kudryavtsev | Afp | Getty Images European stocks …

Read more

Half of workers may struggle to get obesity drug insurance coverage

by Akin Smith
Half of workers may struggle to get obesity drug insurance coverage

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Companies are increasing access to new …

Read more

Ro launches GLP-1 supply tracker to help patients navigate shortages

by Akin Smith
Ro launches GLP-1 supply tracker to help patients navigate shortages

GLP-1 Supply Tracker from Ro.  Courtesy: Ro Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called …

Read more

Digital health companies are launching programs around GLP-1s

by Akin Smith
Digital health companies are launching programs around GLP-1s

Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and is at least twice as effective — is expected to …

Read more

Eli Lilly big GLP-1 investment — plus, CRM, BBY, FL, COST earnings next week

by Akin Smith
Eli Lilly big GLP-1 investment — plus, CRM, BBY, FL, COST earnings next week

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. Wall Street was bouncing …

Read more

Eli Lilly, Novo Nordisk develop weekly insulin

by Akin Smith
Eli Lilly, Novo Nordisk develop weekly insulin

A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them …

Read more

AstraZeneca to boost revenue, release new medicines by 2030

by Akin Smith
AstraZeneca to boost revenue, release new medicines by 2030

The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. Costfoto | Future Publishing | Getty Images LONDON — Pharmaceutical company AstraZeneca …

Read more

Hims & Hers weight loss adds compounded GLP-1 injections

by Anas Siddiqui
Hims & Hers weight loss adds compounded GLP-1 injections

Products of Hims & Hers displayed. Hims & Hers Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday. The …

Read more

Older posts
Newer posts
← Previous Page1 Page2 Page3 Page4 … Page20 Next →

Recent Posts

  • Revolutionizing Business Growth in the UK with Cutting-Edge Technology
  • HBO Almost Cut the ‘Industry’ Season Finale’s Most Shocking Scene
  • Need A Passport ASAP? Here Are 4 Secrets To Getting It Fast.
  • Amazon Asks Its Employees to Use Cedric Instead of ChatGPT
  • Raps’ Boucher motivated as camp opens in hometown
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
  • COOKIES POLICY
  • DISCLAIMER
  • TERMS OF USE
  • DMCA
©2025 ChroniclesLive